Opportunity Information: Apply for TI 21 002
The State Pilot Grant Program for Treatment for Pregnant and Postpartum Women (PPW-PLT) is a discretionary federal grant opportunity offered by the U.S. Department of Health and Human Services through the Substance Abuse and Mental Health Services Administration (SAMHSA), specifically the Center for Substance Abuse Treatment (CSAT). It was published under Funding Opportunity Number TI 21 002 and is associated with CFDA 93.243. The application window opened on December 18, 2020, and the original closing date was February 16, 2021. SAMHSA anticipated making about three awards under this competition, with a maximum award amount (ceiling) of up to $3,000,000 per award.
The core aim of the PPW-PLT program is to strengthen and modernize how states support pregnant and postpartum women who have a primary diagnosis of a substance use disorder, including opioid use disorder. The program emphasizes family-based services, reflecting the reality that effective treatment for pregnant and postpartum clients often requires addressing not only clinical substance use needs, but also parenting, family stability, infant and child well-being, and the practical barriers that can prevent sustained recovery. Rather than focusing narrowly on a single treatment setting, the opportunity is built around improving the overall system of care that women encounter from pregnancy through the postpartum period.
A major theme of the grant is flexibility: SAMHSA’s intent is to give state substance abuse agencies room to use funds in ways that better match real-world needs across the continuum of care. That includes supporting services delivered outside of residential programs, such as nonresidential or community-based settings, which can be essential for women who cannot enter residential care because of childcare responsibilities, employment, transportation issues, or other constraints. By explicitly calling out nonresidential-based settings, the program signals that states should think broadly about treatment access points and service models, not just traditional inpatient or residential approaches.
Another central objective is system coordination. The grant is designed to help state substance abuse agencies lead a coordinated, effective, and efficient statewide approach to services for pregnant and postpartum women with substance use disorders. In practice, this means encouraging states to develop or test new approaches and models of service delivery that reduce fragmentation and improve how clients move through screening, referral, treatment initiation, continuing care, and recovery supports. The “pilot” framing also implies an expectation of innovation and learning: states are encouraged to implement strategies that can demonstrate improved outcomes and inform future scaling, policy decisions, and service design.
Eligibility is listed broadly as “Others,” with additional eligibility details referenced in the full funding announcement. However, the program description repeatedly emphasizes state substance abuse agencies as the entities responsible for managing the coordinated system, so applicants are generally expected to be state-level agencies or closely aligned entities authorized to operate statewide substance use disorder systems and to coordinate partners across treatment and supportive service networks.
In short, the PPW-PLT opportunity funds state-driven efforts to expand and improve family-centered treatment and recovery supports for pregnant and postpartum women with substance use disorders, with particular attention to opioid-related needs, access to services across multiple settings (including nonresidential), and stronger statewide coordination through new or improved service delivery models.Apply for TI 21 002
- The Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis in the health sector is offering a public funding opportunity titled "State Pilot Grant Program for Treatment for Pregnant and Postpartum Women" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.243.
- This funding opportunity was created on Dec 18, 2020.
- Applicants must submit their applications by Feb 16, 2021. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $3,000,000.00 in funding.
- The number of recipients for this funding is limited to 3 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the State Pilot Grant Program for Treatment for Pregnant and Postpartum Women (PPW-PLT)?
The PPW-PLT is a discretionary federal grant opportunity from the U.S. Department of Health and Human Services (HHS) through the Substance Abuse and Mental Health Services Administration (SAMHSA), specifically the Center for Substance Abuse Treatment (CSAT). It supports state-driven efforts to improve treatment and recovery supports for pregnant and postpartum women with substance use disorders.
Which federal agency is offering this grant?
This opportunity is offered by HHS through SAMHSA (CSAT).
What is the Funding Opportunity Number (FON) for this program?
The Funding Opportunity Number is TI 21 002.
What is the CFDA number associated with this grant?
The opportunity is associated with CFDA 93.243.
When did the application window open and close?
The application window opened on December 18, 2020, and the original closing date was February 16, 2021.
How many awards did SAMHSA expect to make under this competition?
SAMHSA anticipated making about three awards.
What is the maximum award amount?
The maximum award amount (ceiling) is up to $3,000,000 per award.
What is the main purpose of the PPW-PLT program?
The core aim is to strengthen and modernize how states support pregnant and postpartum women who have a primary diagnosis of a substance use disorder, including opioid use disorder. The program focuses on improving the overall system of care women encounter from pregnancy through the postpartum period.
Who is the program designed to serve?
The program is designed to support pregnant and postpartum women who have a primary diagnosis of a substance use disorder, including opioid use disorder.
Does the grant focus only on clinical substance use treatment?
No. The opportunity emphasizes family-based services, recognizing that effective support often includes more than clinical treatment alone. It highlights needs related to parenting, family stability, infant and child well-being, and practical barriers that can interfere with sustained recovery.
What does "family-based services" mean in the context of this grant?
Based on the program description, it means designing services that reflect family realities and needs, including supports connected to parenting and family stability and attention to infant and child well-being, alongside substance use disorder treatment.
Is this grant limited to residential treatment programs?
No. A major theme is flexibility, including supporting services delivered outside of residential programs. The grant explicitly points to nonresidential or community-based settings as important access points for women who cannot enter residential care due to childcare, employment, transportation, or other constraints.
Why does the program emphasize nonresidential or community-based settings?
The program notes that many pregnant and postpartum women may face real-world barriers to residential care (such as childcare responsibilities, employment, and transportation). By calling out nonresidential settings, the opportunity encourages states to broaden access and service models across the continuum of care.
What does "continuum of care" refer to in this opportunity?
It refers to the range of services and touchpoints women may move through from pregnancy through postpartum, including screening, referral, treatment initiation, continuing care, and recovery supports, across multiple service settings.
What is the role of system coordination in this grant?
System coordination is a central objective. The grant is designed to help state substance abuse agencies lead a coordinated, effective, and efficient statewide approach, reducing fragmentation and improving how clients move through screening, referral, treatment, continuing care, and recovery supports.
What does "pilot" mean in PPW-PLT?
The pilot framing implies an expectation of innovation and learning. States are encouraged to develop or test new approaches and models of service delivery that can demonstrate improved outcomes and inform future scaling, policy decisions, and service design.
What types of approaches does the program encourage states to implement?
The description encourages new or improved approaches and models of service delivery that strengthen statewide coordination, reduce fragmentation, and improve client movement through key service steps (screening, referral, initiation, continuing care, and recovery supports), including approaches that expand access across multiple settings.
Who is eligible to apply?
Eligibility is listed broadly as "Others," with additional eligibility details referenced in the full funding announcement. However, the program description repeatedly emphasizes state substance abuse agencies as the entities responsible for managing the coordinated system. Applicants are generally expected to be state-level agencies or closely aligned entities authorized to operate statewide substance use disorder systems and coordinate partners across treatment and supportive service networks.
Does the program specifically address opioid use disorder?
Yes. The program includes women with substance use disorders, including opioid use disorder, and notes particular attention to opioid-related needs.
What is the overall intent of how SAMHSA wants states to use these funds?
SAMHSA’s intent is to provide flexibility so state substance abuse agencies can use funds in ways that better match real-world needs across the continuum of care, including supporting family-centered services, nonresidential access points, and improved statewide coordination through new or improved service delivery models.
Browse more opportunities from the same category: Health
Next opportunity: Georgia NRCS Technical Outreach and Education for Fiscal Year 2021
Previous opportunity: FY20 Confidential Close Call Reporting System Peer Review Team
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for TI 21 002
Applicants also applied for:
Applicants who have applied for this opportunity (TI 21 002) also looked into and applied for these:
| Funding Opportunity |
|---|
| Tribal Opioid Response Grants Apply for TI 21 007 Funding Number: TI 21 007 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $37,647,916 |
| Partnering and Communicating Together Apply for CDC RFA PS21 2104 Funding Number: CDC RFA PS21 2104 Agency: Department of Health and Human Services, Centers for Disease Control - NCHHSTP Category: Health Funding Amount: Case Dependent |
| Ryan White HIV/AIDS Program Part F Dental Reimbursement Program Apply for HRSA 21 056 Funding Number: HRSA 21 056 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Using Innovative Intervention Strategies to Improve Health Outcomes among People with HIV - Evaluation Center Apply for HRSA 21 068 Funding Number: HRSA 21 068 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Using Innovative Intervention Strategies to Improve Health Outcomes among People with HIV - Coordinating Center Apply for HRSA 21 076 Funding Number: HRSA 21 076 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Supporting and Improving the Chronic Kidney Disease Surveillance System in the United States Apply for CDC RFA DP21 2107 Funding Number: CDC RFA DP21 2107 Agency: Department of Health and Human Services, Centers for Disease Control - NCCDPHP Category: Health Funding Amount: $1,200,000 |
| Rural Communities Opioid Response Program - Implementation Apply for HRSA 21 088 Funding Number: HRSA 21 088 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $1,000,000 |
| Health Promotion and Disease Prevention Research Centers: 2021 Special Interest Project Competitive Supplements (SIPS) Apply for RFA DP 21 004 Funding Number: RFA DP 21 004 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $3,785,000 |
| THRIVE Water Sanitation and Hygiene Activity Apply for 72069621RFA00001 Funding Number: 72069621RFA00001 Agency: Agency for International Development, Rwanda USAID-Kigali Category: Health Funding Amount: $21,000,000 |
| Certified Community Behavioral Health Clinic Expansion Grants Apply for SM 21 013 Funding Number: SM 21 013 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $2,000,000 |
| Collaborative Research on Influenza, Coronavirus Disease 2019 (COVID-19), and Other Respiratory Pathogens in South Africa Apply for RFA IP 21 003 Funding Number: RFA IP 21 003 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $1,250,000 |
| Grants to Support New Investigators in Conducting Research Related to Preventing Interpersonal Violence Impacting Children and Youth Apply for RFA CE 21 003 Funding Number: RFA CE 21 003 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $125,000 |
| Research Grants for Preventing Violence and Violence Related Injury (R01) Apply for RFA CE 21 004 Funding Number: RFA CE 21 004 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $350,000 |
| Grants to Prevent Prescription Drug/Opioid Overdose-Related Deaths Apply for SP 21 002 Funding Number: SP 21 002 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $850,000 |
| Developing and Disseminating Targeted Immunization Materials Apply for CDC RFA IP21 2104 Funding Number: CDC RFA IP21 2104 Agency: Department of Health and Human Services, Centers for Disease Control - NCIRD Category: Health Funding Amount: Case Dependent |
| Maternal and Child Health Workforce Development Center Program Apply for HRSA 21 043 Funding Number: HRSA 21 043 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $1,970,000 |
| STOP DJEKOIDJO Apply for 72062421RFA00002 Funding Number: 72062421RFA00002 Agency: Agency for International Development, Cote d Ivoire USAID - Abidjan Category: Health Funding Amount: $19,500,000 |
| Paul Coverdell National Acute Stroke Program Apply for CDC RFA DP21 2102 Funding Number: CDC RFA DP21 2102 Agency: Department of Health and Human Services, Centers for Disease Control - NCCDPHP Category: Health Funding Amount: $650,000 |
| Next Generation Sequencing in Post Mortem Tissue from Patients with Parkinsons Disease (U01 Clinical Trial Not Allowed) Apply for RFA NS 21 017 Funding Number: RFA NS 21 017 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Partnering with Professional and Medical Associations to Increase Vaccination Coverage Across Different Racial and Ethnic Adult Populations Experiencing Disparities Apply for CDC RFA IP21 2107 Funding Number: CDC RFA IP21 2107 Agency: Department of Health and Human Services, Centers for Disease Control - NCIRD Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "TI 21 002", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.